U.S. stocks rallied on Friday to close out their dreary February on a brighter note. The S&P 500 jumped 1.6% to trim its loss for the month, enough to make it the worst only since December instead of ...

NewAmsterdam Pharma's obicetrapib lowers LDL-C in Phase 3 trials, showing promise as a CETP inhibitor. Read more on NAMS ...

Heavyweights like Tesla—off 25% YTD—and Palantir—down 20% this month alone—are leading the charge into the red.

The S&P 500, Nasdaq, and Dow Jones Industrial Average each faced significant volatility, reflecting broader concerns about ...

The latest trading session saw Ouster, Inc. (OUST) ending at $8.25, denoting a +1.98% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a gain of 1.59% for the day ...

Nautilus Biotechnology, Inc. eyes commercialization by 2026, facing reflexivity risks and macroeconomic challenges. Click for ...

Shares of Super Micro Computer ended the week lower after recent losses reversed momentum from the company avoiding delisting on Tuesday.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The U.S. stock market was broadly up early Friday afternoon, with all three major benchmarks rising as the Dow Jones Industrial Average traded just shy of a weekly gain. The Dow was up about 140 ...

The stock market lost some of its shine in February, ending lower for the month after the Trump administration’s policy priorities and weak consumer sentiment made investors uneasy about the economy.

US stocks seesawed Friday, but all three major indexes closed the month in the red — a sign of increasing unease in markets.

We recently published a list of 11 Best Crude Oil Stocks To Buy Right Now. In this article, we are going to take a look at ...